Impact of a Meds-to-Beds PCSK9i Initiation Program on LDL-C in Patients Undergoing ASCVD Revascularization. - Lorenzatti D; Greenberg GS; Filtz A; Scotti A; Jaspan VN; Park CM; Kalich B; Jones LK; Kathe N; Di Palo KE; Browne C; Lipsitz E; et al. (JACC. Advances, 2025)